Walgreen WAG posted accelerated growth in sales and earnings in its fiscal first quarter, reported Friday. We will delve deeper into the results, but we do not anticipate a material change to our fair value estimate. Sales increased 16.6%, with comparable-store sales (or comps) rising 9.7% from the ...
The pickings continue to get slimmer for a proven group of top fund managers as the market continues to trade around its all-time high.
Med-tech multinationals look to the East for growth in China.
The corporate bond market will probably struggle to return much above break-even in 2014.
Mistimed sales, Roth-conversion mistakes, and failing to plan for unforeseen events top readers' lists.
Realizing a huge capital gain has put this closed-end fund's share price and discount in the spotlight.
Financial-planning expert Michael Kitces cautions retirees about holding too much cash in their portfolios, as simple rebalancing of stocks and bonds can provide needed income.
With these sectors trading above our fair value estimate, investors should seek firms with established economic moats to help them withstand near-term revenue and operating margin volatility. Plus, get our take on Apple Pay's impact and the ongoing wireless spectrum auction.
It was terrible week for just about every investment category with the exception of U.S. Treasury bills and bonds. U.S. stocks were the "relative" winners, with the S&P down "just" 3.4% for the week. On the other end of the performance scale, emerging-markets equities were down a stunning 6.2% and ...